A groundbreaking blood test for colorectal cancer screening could reshape early detection. Learn how this FDA-approved method ...

DiaCarta Inc., a precision molecular diagnostic company, has announced the publication of its prospective clinical trial data on its blood-based test for triaging FIT (fecal immunochemical ...